{"id":"NCT00986180","sponsor":"Ortho-McNeil Janssen Scientific Affairs, LLC","briefTitle":"NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain","officialTitle":"A Randomized, Double-Blind, Parallel-Group Study of NUCYNTA (Tapentadol) Immediate Release vs. Oxycodone Immediate Release for the Treatment of Acute Low Back Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2010-12","completion":"2010-12","firstPosted":"2009-09-29","resultsPosted":"2012-02-29","lastUpdate":"2012-12-19"},"enrollment":667,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain","Back Pain","Low Back Pain","Back Pain With Radiation"],"interventions":[{"type":"DRUG","name":"NUCYNTA","otherNames":[]},{"type":"DRUG","name":"Oxycodone IR","otherNames":[]}],"arms":[{"label":"001","type":"EXPERIMENTAL"},{"label":"002","type":"ACTIVE_COMPARATOR"}],"summary":"Evaluate how NUCYNTA (tapentadol) immediate release (IR) compares with oxycodone IR in the treatment of acute low back pain.","primaryOutcome":{"measure":"Sum of Pain Intensity Difference (SPID) for Low Back Pain - Summary Statistics at 120 Hours (With Imputation)","timeFrame":"0 hour (prior to first dose) and 120 hours","effectByArm":[{"arm":"NUCYNTA","deltaMin":264.6,"sd":11.43},{"arm":"Oxycodone IR","deltaMin":264,"sd":11.22}],"pValues":[{"comp":"OG000","p":"0.9703"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":74,"countries":["United States"]},"refs":{"pmids":["23703422"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":321},"commonTop":["Vomiting","Nausea","Dizziness","Pruritus","Somnolence"]}}